Author

Baiqing Tang

Fox Chase Cancer CenterORCID 0009-0006-4117-6258Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Daniel KrzizikeiD· 1 shared Hyung‐Ok LeeiD· 1 shared Kathy Qi CaiiD· 1 shared Sapna GuptaiD· 1 shared Warren D. KrugeriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Daniel KrzizikeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyCancer Research CommunicationsPeer-reviewedJul 31, 2026

Febuxostat enhances the anti-tumor efficacy of 2-fluoroadenine and 5-methylthioadenosine in MTAP-deleted cancer

Baiqing Tang, Hyung‐Ok Lee, Daniel Krzizike…·Warren D. Kruger

The paper shows that adding febuxostat to 2FA and MTA increases their anti-tumor effect in MTAP-deleted cancer by reducing XO activity and increasing 2FAMP levels.

DOI 10.1158/2767-9764.crc-26-0193

humanbulk RNA-seq

𝕏 PostBluesky